Cohort Study, Immunosuppressive Agents, Organ Transplantation
Conditions
Brief summary
The goal of this observational study is to explore the different immunosuppressive agents and related outcomes in organ transplantation patients in Taiwan. The main question it aims to answer is the risk of different immunosuppressive agents for infection and survival after transplant. The study enrolled patients who underwent solid organ transplant (SOT), kidney (ICD-9-CM code V42.0), liver (ICD-9-CM code V42.7), or lung (ICD-9-CM code V42.6) transplants. We employed propensity score matching (PSM) to establish a matched cohort. The study will compare SOT patients and general patients to explore the risk of different immunosuppressive agents for infection and survival.
Detailed description
This study used secondary data from the Longitudinal Health Insurance Database (LHID), a subset of the NHIRD provided by the Health and Welfare Data Science Center (HWDC) of the Ministry of Health and Welfare in Taiwan. The HWDC encrypts personally identifying data to protect the privacy of beneficiaries. The database includes detailed clinical records from both the inpatient and outpatient claims of the beneficiaries of Taiwan's National Health Insurance program. This program has provided coverage for up to 99% of the country's population since 1995. The NHIRD can serve as a foundation for the procurement of real-world evidence to support clinical decisions and health-care policy-making. Diagnostic data within the NHIRD from before 2016 and from 2016 or later are respectively coded using International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) and International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes. The database was provided by the HWDC under license and so cannot be made freely available. Requests for access to these data should be made to HWDC (https://dep.mohw.gov.tw/dos/cp-5119-59201-113.html).
Interventions
DRUGImmunosuppressive Agents
Prescribing immunosuppressive agents
Sponsors
Chung Shan Medical University
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Patients who underwent solid organ transplant (SOT)
Exclusion criteria
* Patients who received more than one SOT, had an infectious disease diagnosis before their SOT or had incomplete medical information in the database.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Postoperative infection | From the date of underwent SOTs until the date of incident infection or date of death from any cause, whichever came first, assessed up to 5 years. | Postoperative infection contains Pneumocystis jiroveci pneumonia, cytomegalovirus disease, and Herpes simplex virus |
| Death | From the date of underwent SOTs until the date of death from any cause, assessed up to 5 years. | Death |
Countries
Taiwan
Contacts
Primary ContactChien-Ying Lee, PhD
Outcome results
None listed